Renaissance Capital logo

IPO News & Commentary

Get the latest insights on new stocks

Phase 2 oncology drug developer Starton Holdings decreases shares offered by 25% ahead of $30 million IPO

Starton Holdings logo

Starton Holdings, a Phase 2 developer of controlled release formulations for an approved cancer drug, lowered the proposed deal size for its upcoming IPO on Tuesday. The Paramus, NJ-based company now plans to raise $30 million by offering 5 million shares at a ...read more

Natural gas mineral and royalty business WhiteHawk Minerals prices upsized IPO at $26 midpoint

WhiteHawk Minerals logo

WhiteHawk Minerals, which owns natural gas mineral and royalty interests in the Marcellus and Haynesville Shales, raised $200 million by offering 7.7 million shares at $26, within the $25 to $27 range. The company offered 0.8 million more shares than...read more

Cancer biotech Parabilis Medicines ups shares offered by 33% ahead of $600 million IPO

Parabilis Medicines logo

Parabilis Medicines, a clinical-stage biotech developing engineered peptide therapies for cancer, raised the proposed deal size for its upcoming IPO on Tuesday. The Cambridge, MA-based company now plans to raise $600 million by offering 33.3 million shares at...read more

IPO News By Industry

Be the in-house IPO Expert

Our clients are focused on catalyzing growth and creating value.

Not scouring the web for IPO data.

Get the information you need in minutes, not hours. With IPO Pro, you have the entire US IPO market at your fingertips.